"The words people used to describe their trip experiences could lead to better drugs to treat mental illness." A team at McGill University in Montreal is using natural language processing—the technique that allows voice assistants or search engines to work — to study...

“Finding a data-driven way to structure those experiences to maximize therapeutic benefit, I think is something we can all get excited about," says Sam Freesun Friedman, a senior machine learning scientist at Massachusetts Institute of Technology and Harvard...

 "Based on the growing evidence that these treatments have dramatic and unique benefits, you don’t need to take mushrooms to envision that this field has a vivid future." The University of Calgary has joined a growing number of universities in exploring psychedelic...

“Compared to standard antidepressants, which must be taken for long stretches of time, psilocybin has the potential to enduringly relieve the symptoms of depression with one or two treatments.” More than a year after a study from The Johns Hopkins University...

Recent studies showing the benefits of psilocybin therapy have prompted the push for legalization in Colorado. #psychedelicscience #psilocybin #psychedelicresearch #psychedelicmedicine #research #psychiatry #psychedelicsaroundtheworld #usa #mentalhealth   Link to...

An overview of recent psychedelic decriminalization trends out of Georgia, Missouri, Washington State, Oklahoma, Oregon and Utah.  #psychedelicscience #psilocybin #psychedelicresearch #psychedelicmedicine #decriminalization #psychedelics #USA...

Few things open doors like access to funds. It’s the fuel that lights the way, allowing scientists and researchers and entrepreneurs to build an entirely new industry." An interesting overview on how capital is fuelling innovation, development and confidence in the...

People who have gone through traumatic events should be able to have tools at their disposal that can help them live better lives."  A new $1 million grant will fund researchers at The Johns Hopkins University, Yale University, and New York University to develop a...

In follow up to yesterday's post in The Guardian, Professor Jo Neill outlines the evidence-based case for the rescheduling of psilocybin and other drugs, including the benefits they can bring to health and the UK economy in this blog from Drug Science....

The United Kingdom are urging Cabinet ministers to reclassify psilocybin so that researchers can explore its potential as a medicine. The same demand is being made by people suffering from cluster headaches, amid evidence that psilocybin can help reduce both the...